Summer greetings and top five articles of Q1 & Q2 2026
We would like to thank our readers, subscribers and collaboration partners for a fruitful and eventful Q1 + Q2 2026, and we wish you all a most wonderful summer!
July 17, 2026
The NLS Newsletter will take two weeks off, but our news feed and social media channels will continue to provide you with the latest news and in-depth stories from our exciting life science industry.
Don’t forget to explore our site and archive and learn more about the latest major business deals, initiatives and events.
We wish you all a relaxing summer!
/The NLS Team
Top Five Most Popular Articles Q1 and Q2 2026
1. The power loop: How female leadership and women’s health reinforce each other
In a region celebrated for gender equality, the life science sector tells a different story: women dominate the workforce in many jobs yet remain sidelined in leadership, funding, and research – with consequences that ripple across public health and economic performance.
2. Postdoc Interview: “Just like in life, there is no single correct path in science”
Lionel Leck’s research focuses on pediatric cancer, particularly neuroblastoma – one of the most commonly diagnosed childhood cancers with a poor prognosis.
3. New coalition aims to strengthen Europe’s life science investment ecosystem
The European Life Sciences Coalition (ELSC) aims to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilizing greater levels of private and public investment across the sector.
4. Saga Diagnostics acquired by Roche
Saga Diagnostics has entered into an agreement to be acquired by Foundation Medicine, an independent subsidiary of Roche, for a deal value of up to USD 595 million, including commercial and regulatory milestone payments.
5. Novo Nordisk Foundation secures BII to 2035
The funding will enable BII to expand its activities into new strategic areas and geographies, and support even more entrepreneurs and start-up-companies, thereby strengthening innovation in Denmark and Europe.
Published: July 17, 2026
